Clinical Trials Logo

Gastroesophageal Reflux Disease clinical trials

View clinical trials related to Gastroesophageal Reflux Disease.

Filter by:

NCT ID: NCT01777867 Completed - Clinical trials for Gastroesophageal Reflux Disease

Cough Reflex Sensitivity and Bronchial Hyper-responsiveness

Start date: December 2012
Phase: N/A
Study type: Observational

The aim of this study is to provide pilot data on the possible gastrointestinal predictors of respiratory hyper-responsiveness and how these relate to the clinical sub-types of gastroesophageal reflux disease (GERD) and visceral acid hypersensitivity.

NCT ID: NCT01776827 Completed - Clinical trials for Gastroesophageal Reflux Disease

Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital

Start date: May 22, 2012
Phase:
Study type: Observational

To study the long term outcome of Laparoscopic Hiatal Hernia Repair with human acellular dermal matrix Alloderm (LifeCell, Branchburg, NJ) mesh.

NCT ID: NCT01753128 Completed - Clinical trials for Gastroesophageal Reflux Disease

Efficacy of Imipramine for Treatment of Patients With Esophageal Hypersensitivity/ Functional Heartburn

Start date: December 2012
Phase: Phase 3
Study type: Interventional

Esophageal hypersensitivity/Functional heartburn are common among non-erosive reflux disease (NERD) patients who do not response to proton pump inhibitors. Whether tricyclic antidepressant improves NERD patient's symptoms remains unknown Aim of this randomized controlled trial study is to determine the efficacy of imipramine, which could increase esophageal pain thresholds in healthy volunteers, in comparison with placebo for treatment patients with esophageal hypersensitivity or functional heartburn evaluated by improvement of specific-symptom score and quality of life

NCT ID: NCT01742377 Completed - Clinical trials for Gastroesophageal Reflux Disease

Minimal Change Esophagitis by i-Scan Endoscopy in Dyspeptic Patients

MCE
Start date: February 2010
Phase: N/A
Study type: Observational

The purpose of this study to assess efficacy of SE endoscopy in the detection of MCE in dyspeptic patients with or without GERD diagnosed by GerdQ or by endoscopy + PHM and in normal volunteers.

NCT ID: NCT01733810 Completed - Clinical trials for Gastroesophageal Reflux Disease

The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis

Start date: February 1, 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the role of hypoxia inducible factor (HIF)-2a on the production of inflammatory cytokines that lead to reflux esophagitis.

NCT ID: NCT01710462 Withdrawn - Clinical trials for Gastroesophageal Reflux Disease

Clinical Study, Multicenter, Randomized With 2 Arms of Pantoprazole + Domperidone and Pantoprazole Isolated at the Gastroesophageal Reflux Disease

PANDA
Start date: August 2013
Phase: Phase 3
Study type: Interventional

This superiority phase III study to compare the combination of Pantoprazole and Domperidone with Pantoprazole isolated to the treatment of gastroesophageal reflux disease. The hypothesis is that combination of the two medication at the unique capsule is better to the patients because decrease the quantity of times the patients need to take medicines during the day.

NCT ID: NCT01696734 Recruiting - Clinical trials for Gastroesophageal Reflux Disease

Domperidone in Treating Patients With Gastrointestinal Disorders

Start date: October 23, 2012
Phase: Phase 3
Study type: Interventional

This phase III trial studies how well domperidone works in treating patients with gastrointestinal disorders. Domperidone may help control chronic gastrointestinal disorders and their symptoms, such as pain, bloating, and nausea and vomiting, by stimulating contraction of the stomach to increase its ability to empty itself of food.

NCT ID: NCT01682265 Completed - Clinical trials for Gastroesophageal Reflux Disease

Stretta In Reflux Uncontrolled by IPP

SIRUP
Start date: March 26, 2012
Phase: N/A
Study type: Interventional

The aim of the study is to compare the Stretta procedure and the Sham procedure efficiency 6months post-procedure in reflux uncontrolled by intake of Inhibitors of Protons Pump (IPP) patients.

NCT ID: NCT01642615 Completed - Clinical trials for Gastroesophageal Reflux Disease

Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents

Start date: July 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and effectiveness of treatment with once daily oral administration of dexlansoprazole delayed-release capsules in adolescents with erosive esophagitis (EE) and for maintenance of healed EE and relief of heartburn.

NCT ID: NCT01642602 Completed - Clinical trials for Gastroesophageal Reflux Disease

Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents

Start date: July 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study was to assess the safety and effectiveness of once daily oral administration of dexlansoprazole delayed-release capsules in adolescent participants with symptomatic non-erosive gastroesophageal reflux disease (GERD).